Quanto Agroworld
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Subscription
- Big non-institutionalbNII · above ₹10 lakh
- 1.21×
- Retail individualRII · up to ₹2 lakh
- 0.79×
Bids received
The demand behind each multiple — what was offered, what was bid for, and what those bids are worth
| Category | Shares offered | Shares bid for | Bids (₹ Cr) | Times |
|---|---|---|---|---|
| Non-institutional | 21,98,000 | 36,50,000 | ₹24.46 Cr | 1.66× |
| Retail individual | 22,00,000 | 17,28,000 | ₹11.58 Cr | 0.79× |
| Total | 43,98,000 | 61,24,000 | ₹41.03 Cr | 1.39× |
Times subscribed is the figure published for each category, not shares bid for divided by shares offered — a category's multiple is struck against its own allottable base, which is not always the offered count shown beside it. Observed 17 Sept, 05:11 pm IST; the registrar publishes the final basis of allotment.
Issue details
- IPO date
- 15 Sep 2026 – 17 Sep 2026
- Listing date
- 22 Sep 2026
- Face value
- ₹10 per share
- Price band
- ₹67
- Issue price
- ₹67 per share
- Lot size
- 2,000 shares
- Sale type
- Fresh capital
- Issue type
- Fixed Price issue
- Listing at
- BSE
- Total issue size
- ₹31.02 Cr
- Fresh issue
- ₹29.47 Cr 43,98,000 shares
- Offer for sale
- ₹0 Cr 0 shares
- Market cap at offer price
- ₹117 Cr
- Promoter holding
- 61.49% → 45.21% pre-issue → post-issue
- ISIN
- INE0OAB01019
- CIN
- U01100MH2018PLC306927
- Registrar
- MUFG Intime India Pvt.Ltd.
- Lead managers
- Sobhagya Capital Options Pvt.Ltd.
- Registered office
- 109, Garnet Paladium, ITT Bhatti, Western Express Highway, Behind Express Zone, Goregaon East, Mumbai, Maharashtra – 400063
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| QIB | 0 | 0.00% | 0.00% |
| Anchor investor · within QIB | 0 | — | 0.00% |
| NII (HNI) | 21,99,000 | 50.00% | 47.49% |
| bNII > ₹10L · within NII | 21,99,000 | — | 47.49% |
| sNII < ₹10L · within NII | 0 | — | 0.00% |
| Retail (RII) | 21,99,000 | 50.00% | 47.49% |
| Employee | 0 | — | 0.00% |
| Market maker | 2,32,000 | — | 5.01% |
| Total issue | 46,30,000 | — | 100.00% |
Net offer to the public of 43,98,000 shares, out of a total issue of 46,30,000. Indented rows sit inside the category above them and are not added to it.
Application size
Minimum 2,000 shares per lot, in multiples, at ₹67
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 2,000 | ₹1,34,000 |
| S-HNI (min) | 2 | 4,000 | ₹2,68,000 |
| S-HNI (max) | 7 | 14,000 | ₹9,38,000 |
| B-HNI (min) | 8 | 16,000 | ₹10,72,000 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Anchor investors
Institutional allocation placed a day before the issue opens, carved out of the QIB portion and locked in after listing.
Valuation and performance
Valuation at offer price
₹67 per share
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 6.52 | 4.79 |
| P/E (×) | 10.28 | 13.99 |
| Price to book (×) | 2.53 | — |
| Market cap | — | ₹117 Cr |
Key performance indicators
Latest reported period, standalone
- Return on net worth
- 24.68%
- ROCE
- 25.62%
- Debt / equity
- 0.16
- PAT margin
- 20.78%
- EBITDA margin
- 29.54%
- NAV per share
- ₹26.43
- Price to book
- 2.53
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.
Company financials
Standalone ·₹ crore unless a row shows % or ×, as reported in the offer document
| Period ended | FY26 | FY25 | FY24 |
|---|---|---|---|
| Profit and loss | |||
| Total income | 40.35 | 16.49 | 15.56 |
| Revenue from operations | 40.35 | 16.49 | 15.55 |
| Other income | 0 | 0 | 0.01 |
| Total expenses | 31.94 | 10.27 | 9.8 |
| Operating profit | 8.41 | 6.22 | 5.76 |
| Operating margin | 20.84% | 37.72% | 37.02% |
| Profit before tax | 8.41 | 6.22 | 5.76 |
| Profit after tax | 8.38 | 6.63 | 5.37 |
| PAT margin | 20.77% | 40.21% | 34.51% |
| Balance sheet | |||
| Total assets | 40 | 33.43 | 24.82 |
| Current assets | 20.79 | 11.86 | 7.3 |
| Current liabilities | 4.41 | 6.75 | 4.59 |
| Total liabilities | 5.94 | 7.76 | 5.78 |
| Net worth | 34.05 | 25.67 | 19.04 |
| Current ratio | 4.71× | 1.76× | 1.59× |
| Return on equity | 24.61% | 25.83% | 28.20% |
| Cash flow | |||
| Operating cash flow | 0.53 | 6.88 | 7.77 |
| Investing cash flow | -0.46 | -6.61 | -7.64 |
| Financing cash flow | -0.06 | -0.23 | -0.21 |
| Net cash flow | 0 | 0.04 | -0.08 |
Objects of the issue
Stated use of the net proceeds— open a row for the issuer's full explanation
1 Capital Expenditure for Distillation Plant at Ravalgaon, Maharashtra ₹3.79 Cr
The company proposes to establish a new distillation plant to expand production capacity by installing plant, machinery and fittings. This expansion aims to strengthen manufacturing capabilities and support long-term growth strategy.
2 Capital Expenditure for expansion and Development of Farms ₹15.23 Cr
The company proposes to scale cultivation of Medicinal and Aromatic Plants (MAPs) and strengthen biomass availability, B2B supply capability, and essential oil operations through improved volume reliability and quality consistency by expanding and developing farmlands.
3 Prepayment or repayment of all or a portion of certain outstanding borrowings availed by the Company ₹3.63 Cr
The company proposes to repay/prepay certain borrowings to reduce outstanding indebtedness and interest costs, maintain favorable debt-equity ratio and enable further utilization of funds from internal accruals for business growth and expansion.
4 To meet General Corporate Purpose ₹4.65 Cr
The company proposes to utilize funds for strategic initiatives including investments or acquisitions, brand building and promotional activities, strengthening infrastructure and systems, pre-operative expenses, provision for contingencies and ongoing general corporate purposes.
About Quanto Agroworld
Quanto Agroworld Limited, incorporated on March 21, 2018, is an integrated medicinal and aromatic plants (MAPs) and essential oils company. The company operates a farm-to-formulation business model, cultivating lemongrass and other medicinal and aromatic plants across approximately 424.04 acres of operational land in Ravalgaon, Maharashtra, under an agreement with Maharashtra State Farming Corporation Limited. Through its distillation facilities, the company extracts and produces essential oils via steam distillation. The company supplies essential oils and botanical extracts to B2B customers in pharmaceuticals, cosmetics, nutraceuticals, and food flavoring sectors. The company was originally incorporated as a private limited entity and converted to public limited status on September 7, 2023.
Management
Mr. Surendra Kumar Babulal Agarwal
CEO
Mrs. Sangeeta Surendra Agarwal
MD
Strengths
As stated in the offer document
Vertically integrated operating structure
The company operates through an integrated structure covering land access, cultivation, harvesting, post-harvest handling, steam distillation and dispatch of finished products, reducing dependence on third-party intermediaries and enabling closer coordination between harvesting and processing activities.
Structured access to cultivation land with multi-year visibility
The company conducts core cultivation activities on agricultural land leased through Maharashtra State Farming Corporation Limited (MSFCL), providing visibility over land availability and tenure for advance crop planning and phased land development.
Cost-efficient cultivation and processing configuration
The company undertakes cultivation and processing activities in-house with harvested biomass processed at distillation facilities located in close proximity to cultivation areas, reducing transportation requirements and handling losses.
Experienced promoter-led management and operational oversight
The company is led by promoters who have been associated with operations since inception and have played a central role in land aggregation, expansion of cultivated acreage and commissioning of processing infrastructure.
Asset-light and scalable operating model
The company follows an asset-light approach to land access by operating primarily on leased agricultural land rather than owned farmland, supporting flexibility in expansion planning and reducing fixed cost exposure.
Quality-focused operations and process discipline
The company operates under a quality-oriented framework supported by ISO 9001:2015 certification and holds Kosher and Halal certifications, with quality control measures integrated across cultivation, harvesting and processing stages.
Sustainability-oriented farming and resource utilisation practices
The company focuses on chemical-free and regenerative farming practices with post-distillation biomass reused internally for composting or boiler fuel, supporting a circular operating system and reducing waste.
Risk factors
As stated in the offer document
Customer Concentration Risk
The company generates a significant percentage of revenue from few clients, with the top customer contributing 54.57% of revenue in FY2026 and top 5 customers contributing 85.49%. The company has no long-term agreements with major customers, and loss of any significant customer could materially impact business operations and profitability.
Trade Receivables Collection Risk
The company's inability to collect trade receivables from customers in a timely manner could adversely affect business operations and cash flows. Trade receivables totaled ₹940.13 lakhs as of March 31, 2026, with ₹553.91 lakhs outstanding for more than six months.
Weather and Climate-Related Operational Risk
The company's business is significantly exposed to adverse weather patterns including irregular monsoons, floods, droughts, and climate change effects. These conditions could disrupt agricultural production, reduce crop yields, increase input costs, and impact the availability of raw materials required for operations.
Related Party Transaction Dependency
A significant portion of the company's purchases has been from related party Quanto Agritech Private Limited, representing 23.31% of total expenses in FY2024. This concentration exposes the company to vendor concentration risk, supply disruptions, and potential conflicts of interest.
Geographic Revenue Concentration Risk
The company's operations are concentrated in Maharashtra and Gujarat, with 99.26% of revenues from Maharashtra and 0.74% from Gujarat as of March 31, 2026. This geographic concentration exposes the company to region-specific economic conditions, regulatory changes, and climatic risks.
Regulatory Compliance and Legal Risk
The company has experienced multiple regulatory non-compliances under the Companies Act, 2013, including delays in statutory filings and private placement compliance issues. The company has filed compounding applications with the ROC, and adverse regulatory actions could impact business operations and reputation.
Operational Infrastructure Risk
The company's existing and proposed distillation plants operate under partially covered shed structures, which may expose operations to environmental factors, weather conditions, and regulatory scrutiny. This arrangement may require additional capital expenditure or operational modifications.
Working Capital and Cash Flow Risk
The company has experienced negative cash flows from investing activities (₹46.11 lakhs in FY2026) and financing activities (₹6.44 lakhs in FY2026). Continued negative cash flows may limit funds for operations, expansion plans, and future capital requirements.
Company Analysis
from PROSPECTUSQuanto Agroworld Limited cultivates medicinal and aromatic plants and produces essential oils through steam distillation for B2B supply in the pharmaceutical, cosmetics, and nutraceutical sectors.
Quanto Agroworld Limited, incorporated on March 21, 2018, is an integrated medicinal and aromatic plants (MAPs) and essential oils company. The company operates a farm-to-formulation business model, cultivating lemongrass and other medicinal and aromatic plants across approximately 424.04 acres of operational land in Ravalgaon, Maharashtra, under an agreement with Maharashtra State Farming Corporation Limited. Through its distillation facilities, the company extracts and produces essential oils via steam distillation. The company supplies essential oils and botanical extracts to B2B customers in pharmaceuticals, cosmetics, nutraceuticals, and food flavoring sectors. The company was originally incorporated as a private limited entity and converted to public limited status on September 7, 2023.
Objects of the Issue
- Capital Expenditure for Distillation Plant at Ravalgaon, Maharashtra ₹379.24 Lakhs p.90
- Capital Expenditure for expansion and Development of Farms ₹1,522.94 Lakhs p.94
- Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our Company ₹362.66 Lakhs p.98
- General Corporate Purpose ₹465.00 Lakhs p.99
- Not disclosed in this section (page 108-157 contains industry overview and company business overview; Objects of the Offer would typically appear in offer structure section)
Issue Structure
- Total Issue
- ₹3,102.10 Lakhs (46,30,000 Equity Shares)
- Fresh Issue
- 46,30,000 Equity Shares of ₹10/- each at an Issue Price of ₹67/- per equity share aggregating to ₹3,102.10 Lakhs
- Price Band
- ₹67/- per Equity Share (Fixed Price)
- Face Value
- ₹10/- per Equity Share
Business Model
The company operates an integrated farm-to-formulation model: it cultivates medicinal and aromatic plants on leased farmland, processes the harvested biomass through steam distillation to extract essential oils, and supplies the finished products to B2B customers in pharmaceutical, cosmetic, nutraceutical, and food industries.
Business Segments
SWOT Analysis
- • No publicly traded market history reduces valuation pressure(p.45)
- • Strong profitability and return metrics(p.104)
- • High EBITDA margins demonstrate operational efficiency(p.106)
- • Solid revenue growth trajectory(p.105)
- • Positive Net Asset Value per share trajectory(p.104)
- • Vertically integrated MAP value chain from cultivation to processing(p.157)
- • Structured multi-year land access with government lease providing tenure visibility(p.157)
- • Co-located cultivation and processing reduces post-harvest losses and improves oil quality(p.157)
- • ISO 9001:2015 certified operations with Kosher and Halal certifications(p.157)
- • Asset-light model with leased rather than owned land reduces capital requirements(p.157)
- • Sustainability-focused practices including rainwater harvesting and biomass reuse(p.157)
- • Currently does not depend on external suppliers for core raw materials(p.155)
- • Vertically integrated cultivation-to-processing model with 424+ acres of owned/controlled farmland(p.181)
- • On-site steam distillation facility eliminates post-harvest delays and improves oil yields(p.171)
- • Sustainable zero-waste operating model with post-distillation biomass reuse(p.174)
- • Strong positioning in high-growth wellness and essential oils sectors(p.174)
- • Experienced and diversified management team with 28+ years in agriculture(p.174)
- • Structural market advantage due to persistent supply deficit in MAPs and essential oils(p.159)
- • ISO 9001:2015, Kosher and Halal certifications for quality assurance(p.177)
- • Vertically integrated farm-to-ingredient model enabling cost control and quality assurance(p.274)
- • Large consolidated MAP cluster with 737 acres of cultivated land, 424 acres on long-term government lease(p.274)
- • International quality certifications (ISO 9001:2015, Kosher, Halal)(p.274)
- • Strong profitability with PAT growing 26.44% year-on-year in FY 2025-26(p.280)
- • Revenue growth of 144.63% in FY 2025-26 driven by higher business volumes and capacity utilization(p.279)
- • Stable long-term government land lease reducing land acquisition risk(p.274)
- • Low debt-to-equity ratio of 0.16 indicating conservative capital structure(p.269)
- • Integrated operational model enhancing quality control and cost efficiency(p.289)
- • Established long-standing relationships with key customers(p.289)
- • High customer concentration risk with top customer representing 54.57% of revenue(p.23)
- • Significant portion of purchases from related party subsidiary(p.21)
- • Negative cash flows from investing and financing activities in certain periods(p.22)
- • Only 11 employees with heavy reliance on contract labour without formal agreements(p.25)
- • Lease arrangements for registered office and farmland without ownership(p.25)
- • Past regulatory non-compliances and procedural violations(p.20)
- • Trademark registered in Director's name, not Company name(p.37)
- • Multiple auditor changes in recent years(p.32)
- • Outstanding borrowings of ₹547.58 lakhs with covenant compliance risks(p.34)
- • Heavy dependence on monsoon rainfall for agricultural production(p.46)
- • Significant auditor turnover and compliance instability(p.61)
- • Volatile inflation in India increases operating costs unpredictably(p.46)
- • Material exposure to foreign exchange fluctuations(p.47)
- • Low cash position relative to operational needs(p.51)
- • Severe customer concentration with top customer accounting for over 54% of revenue(p.155)
- • Capacity utilization declined significantly to 41.91% in FY2026 from 78.22% in FY2025(p.153)
- • Essential oil revenue collapsed from 8.32% to 2.82% of total revenue between FY2025 and FY2026(p.154)
- • Limited subsidiary QAPL has leased only 165.33 acres from fragmented private landholders(p.149)
- • High dependence on MSFCL land with additional 312.57 acres still under development(p.149)
- • Dependence on limited product portfolio concentrated around lemongrass(p.174)
- • Geographic concentration of operations in single cluster (Ravalgaon, Nashik)(p.174)
- • Technology and traceability systems still under development(p.174)
- • Dependence on government-leased land subject to renewal and regulatory terms(p.174)
- • Significant capacity underutilization historically at legacy manufacturing locations(p.179)
- • Limited permanent workforce with heavy reliance on hired labour(p.182)
- • Significant customer concentration with top 1 customer representing 54.57% of FY 2025-26 revenue(p.288)
- • Capacity utilization declined significantly to 41.91% in FY 2025-26 due to operational shift(p.277)
- • Operating cash flow declined substantially to ₹52.81 lakhs in FY 2025-26 from ₹688.40 lakhs in FY 2024-25(p.284)
- • Material costs increased to 67.85% of revenue in FY 2025-26 from 38.96% in FY 2024-25(p.279)
- • PAT margin declined from 40.21% to 20.78% despite revenue growth(p.280)
- • Company does not have formal dividend policy; no dividend paid since incorporation(p.234)
- • High revenue concentration with limited number of customers(p.289)
- • Top 10 customers account for majority of revenue(p.289)
- • Outstanding income tax demands against promoters(p.291)
- • Significant land expansion planned to increase MAPs cultivation capacity(p.95)
- • Capacity expansion through new distillation plant at Ravalgaon(p.90)
- • Scaling from 11.25 to 56.25 MTPA installed capacity post-expansion(p.91)
- • Public market access and brand enhancement through listing(p.89)
- • Debt reduction and improved financial flexibility from IPO proceeds(p.98)
- • Global lemongrass oil market projected to grow from USD 61 million (2024) to USD 113-123 million by 2032-33(p.143)
- • Global medicinal and aromatic plants market expanding from USD 410.3 billion to USD 890.7 billion by 2034(p.128)
- • Citral demand as industrial feedstock for Vitamin A and ionone synthesis(p.142)
- • Multi-product value capture from lemongrass including biomass for biofuels and paper(p.147)
- • Rising clean-label and natural ingredient demand across FMCG, cosmetics and pharmaceuticals(p.142)
- • India positioned as global leader in lemongrass and other aromatic crops with export growth(p.124)
- • Government support for agro-processing and MAPs through subsidies and infrastructure schemes(p.143)
- • Expansion into additional MAP crops and botanical ingredients beyond lemongrass(p.174)
- • Potential to replicate integrated cluster model across new geographic regions(p.174)
- • Rising global demand for sustainable, traceable, natural ingredients(p.174)
- • Scope for strategic partnerships with FMCG, nutraceutical and wellness companies(p.174)
- • Expansion into additional processed formats and value-added products(p.158)
- • Phased capacity expansion aligned with cultivation growth (11.25 MTPA to 56.25 MTPA)(p.179)
- • Export market expansion opportunities with development of distributor and institutional buyer relationships(p.158)
- • Expansion of customer base to reduce revenue concentration risk(p.288)
- • Growing demand for essential oils and specialty ingredients in pharma, FMCG, and fragrance industries(p.275)
- • Opportunity to increase cultivation acreage and productivity through subsidiary expansion(p.274)
- • Improvement in operational efficiency through mechanization and centralized supervision(p.275)
- • Higher capacity utilization potential as operations reach full scale at Ravalgaon(p.277)
- • Mitigation of competitive pressures through focus on value-added products(p.289)
- • Potential to expand customer base and market reach(p.289)
- • Dependence on agricultural commodities with weather and climate volatility(p.22)
- • Exposure to region-specific risks with 99.26% revenue from Maharashtra(p.30)
- • Extensive regulatory requirements and compliance changes(p.27)
- • Competition from organized and unorganized players(p.39)
- • Volatility in raw material prices and agricultural input costs(p.37)
- • Economic and political uncertainties affecting Indian markets(p.44)
- • Global and domestic economic downturns reduce market demand(p.46)
- • Indian economy slowdown directly impairs business performance(p.46)
- • Infrastructure inadequacies disrupt normal operations(p.46)
- • Terrorism, civil unrest, and geopolitical risks destabilize markets(p.46)
- • Regulatory changes and legal uncertainties increase compliance burden(p.46)
- • India credit downgrade constrains debt financing availability and costs(p.46)
- • No guarantee of active secondary market or liquidity for equity shares(p.45)
- • Climate variability and rainfall dependency affecting yield and quality in Indian agriculture(p.140)
- • Quality consistency and adulteration risks in botanical supply chains(p.141)
- • Rising agricultural input costs and labour availability constraints(p.141)
- • Stringent pesticide residue limits and compliance requirements in export markets(p.146)
- • Agricultural market price volatility and supply-demand imbalances affecting margins(p.141)
- • Infrastructure and logistics limitations impacting post-harvest handling and supply chain efficiency(p.141)
- • Rising competition from synthetic biology and fermentation-derived alternatives to natural extraction(p.146)
- • Agricultural and climatic risks affecting crop productivity and yield variability(p.174)
- • Price volatility in essential oils and botanical extracts market(p.174)
- • Regulatory, environmental or land-policy changes impacting operations(p.174)
- • Intense competition from domestic and international essential-oil producers(p.174)
- • Highly competitive landscape with established processors like Synthite, Plant Lipids, Kancor(p.181)
- • International competition from global players like Young Living, doTERRA, Indesso, Tienyuan Biotech(p.181)
- • Seasonality and harvest cycles affecting raw material availability(p.160)
- • Adverse agro-climatic conditions including droughts, excessive rainfall, and pest infestations affecting crop yield(p.275)
- • Volatility in commodity prices and market demand for lemongrass essential oil(p.275)
- • Input cost inflation including cultivation, labour, power, fuel, and logistics expenses(p.275)
- • Exposure to agricultural sector cyclicality and weather-dependent operations(p.287)
- • Dependence on regulatory compliance and agricultural certifications for market access(p.275)
- • Loss of key customer relationships could materially impact revenues(p.288)
- • Inflationary pressures on raw material, labour, and operational costs(p.287)
- • Competitive pressure from multiple players in the market(p.289)
- • Competition affecting pricing, volumes and margins(p.289)
Promoters
| Name | Role | Pre-Issue | Post-Issue |
|---|---|---|---|
| Surendra Kumar Babulal Agarwal | Promoter | 40.34% | 29.67% |
| Sangeeta Surendra Agarwal | Promoter | 21.15% | 15.55% |
| Gaurav Surendra Agarwal | Promoter | — | — |
| Not explicitly named in this section | Promoter | — | — |
| Surendra Kumar Babulal Agarwal | Promoter | — | — |
| Sangeeta Surendra Agarwal | Promoter | — | — |
| Gaurav Surendra Agarwal | Promoter | — | — |
| Surendra Kumar Babulal Agarwal | Promoter | 51,86,503 shares (40.34%) | — |
| Sangeeta Surendra Agarwal | Promoter | 27,18,941 shares (21.15%) | — |
| Gaurav Surendra Agarwal | Promoter | — | — |
| Sangeeta Agarwal | Promoter and Managing Director | — | — |
| Surendra Kumar Babulal Agarwal | Promoter and Director | — | — |
| Surendra Kumar Babulal Agarwal | Promoter | — | — |
| Sangeeta Surendra Agarwal | Promoter | — | — |
Auto-extracted from the company's PROSPECTUS using AI, with each fact linked to its source passage (hover any row to see the quote & page). Provided for research only, not investment advice — verify against the official PROSPECTUS before relying on it.
Offer documents
Peer comparison
The comparable listed companies named in the offer document, as on 31 Mar 2026
| Company | EPS | NAV | P/E | P/BV | RoNW |
|---|---|---|---|---|---|
| Quanto Agroworld Limited THIS ISSUE | 6.52 | 26.43 | 13.99, computed at the offer price | 2.53, computed at the offer price | 24.68% |
| 1.56 | 208.63 | 336.59 | 2.59 | 3.66% | |
| 6.40 | 98.40 | 23.26 | 1.52 | 3.71% |
Blank cells are figures the offer document does not publish. This issue is unlisted, so it has no market price and the document publishes no multiple for it — its P/E and P/BV here are computed at the offer price, on the post-issue share count, and are comparable to a listed peer's.